Bluejay Diagnostics (BJDX) Depreciation and Depletion (2022 - 2026)

Bluejay Diagnostics has reported Depreciation and Depletion for 5 years, with the latest figure at $27763.0 in Q1 2026.

• Quarterly Depreciation and Depletion rose 50.88% year-over-year to $27763.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $83544.0 (up 12.43% YoY) and the FY2025 annual result came in at $74182.0, down 1.9% from the prior year.
• Depreciation and Depletion grew to $27763.0 in Q1 2026 per BJDX's latest filing, from $27415.0 in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $253175.0 in Q2 2023 and troughed at $10624.0 in Q3 2025.
• A 5-year average of $57815.8 and a median of $27415.0 in 2025 frame the typical range for Depreciation and Depletion.
• The sharpest annual moves came in 2023 and 2024: Depreciation and Depletion jumped 501.02% in 2023, then tumbled 93.02% in 2024.
• Over 5 years, Depreciation and Depletion stood at $30682.0 in 2022, then declined by 27.18% to $22342.0 in 2023, then slipped by 11.49% to $19775.0 in 2024, then surged by 38.63% to $27415.0 in 2025, then climbed by 1.27% to $27763.0 in 2026.
• According to Business Quant data, Depreciation and Depletion over the past three periods registered $27763.0, $27415.0, and $10624.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.